FDA Inspection
ALS Group USA CorpALS Group USA Corp – FDA Inspection, Feb 6, 2017
Record Details
This FDA Inspection record concerns ALS Group USA Corp, with an inspection on February 6, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a806e824-bff0-4b4f-b486-ca14d59242ee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009089
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.194(a)(8)Second person sign off
- 21 CFR 211.182Personnel dating/signing equipment log
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ALS Group USA Corp
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ALS Group USA Corp
- FDA Inspection 1166549 - 2022-03-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.